Stock MESC LOPHOS HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Lophos Holdings Inc.

Equities

MESC

CA5439371066

Delayed Canadian Securities Exchange
Other stock markets
 20:44:59 17/05/2024 BST 		5-day change 1st Jan Change
0.055 CAD 0.00% Intraday chart for Lophos Holdings Inc. -8.33% +37.50%
04-15 ThreeD Capital Inc. announced that it expects to receive CAD 0.1275 million in funding from Lophos Holdings Inc. CI
04-15 ThreeD Capital Inc. entered into a securities purchase agreement to acquire 2.5% stake in Lophos Holdings Inc. for CAD 0.05 million. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lophos Pharmaceuticals Corp. Receives Traditional Blessing for Napanee Site in Honor of Indigenous Heritage
NE
Lophos Pharmaceuticals Corp. Enters Into Letter of Intent to Acquire the Assets of Magicactus.com
AQ
Lophos Pharmaceuticals Corp. Commences Peyote Research Protocol
AQ
Lophos Pharmaceuticals Corp. Expands Peyote Cultivation with the Successful Planting of 3,000 Seeds
AQ
Lophos Pharmaceuticals’ Licensed Site Celebrates Successful Building Occupancy
AQ
ThreeD Capital Inc. and Lophos Holdings Inc. Announce Strategic Partnership
AQ
ThreeD Capital Inc. Announces Securities Purchase Agreement with Lophos Holdings Inc.
AQ
ThreeD Capital Inc. announced that it expects to receive CAD 0.1275 million in funding from Lophos Holdings Inc.
CI
ThreeD Capital Inc. entered into a securities purchase agreement to acquire 2.5% stake in Lophos Holdings Inc. for CAD 0.05 million.
CI
Lophos Holdings Inc. Celebrates Successful Conclusion of Inaugural Annual General Meeting, Confirms Board Members and Stock Options Plan
AQ
Lophos Holdings Inc. Announces Board Changes
CI
Lophos Pharmaceuticals Partners With Carmichael Engineering Ltd. for HVAC Project, Anticipates Expedited Building Occupancy
AQ
Lophos Confirms Appearance at Benzinga Capital Conference in Hollywood, Florida and Finalizes Annual General Meeting
AQ
Lophos Holdings Inc. Finalizes the Development of a New Research Protocol for Lophophora Williamsii
CI
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Research Protocol for Lophophora Williamsii (Peyote)
AQ
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Synthetic Mescaline Protocol
AQ
Lophos Pharmaceuticals Corp. Finalizes the Development of A New Synthetic Mescaline Protocol
CI
Lophos Pharmaceuticals Corp. Finalizes Product Release Specifications for Fresh and Dried Peyote (Lophophora williamsii)
AQ
Health Canada Endorses Lophophora Williamsii, Elevating Lophos Holdings Inc. as a Leader in Natural Health Innovation
AQ
Lophos Pharmaceuticals Corp. Receives Health Canada Approval for Expanded Controlled Substance Operations Following HVAC Revisions
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MESC Stock
  4. News Lophos Holdings Inc.